The ReShape dual balloon system has been available in Europe since 2007.
Up, up and away: Intragastric
balloons approved for weight loss
By Mark C. Weissler, M.D., FACS
Every year I am amazed by the breadth of knowledge and information presented at the annual Clinical Con- gress. I fnd it deeply satisfying to realize how much
I can still enjoy and learn from the wide variety of topics
presented from all the surgical specialties.
First, there is so much new to absorb in each of our
specialties and the Clinical Congress is a must in terms of
hearing frsthand about innovation and change. The technical aspects of surgical techniques seemingly unrelated to
my own area of specialization often have parallels to my
own practice and raise questions or possible answers to
problems I face in my own feld.
Second, the vast amount of information about topics
germane to all surgeons, such as surgical ethics, professionalism, critical care, surgical fundamentals, information
technology, new surgical technology, advocacy, and more,
really can’t be found in any other venue.
The College has worked hard to ofer learning environments that meet a variety of needs. The Town Hall
meetings give groups of surgeons with a common interest
the opportunity to freely discuss a wide variety of topics
in a relatively unstructured environment. There will be
20 Town Hall meetings this year ranging from “
Development of a Rural Track in Residency” to “The Surgeon
VOL. 11 • NO. 9
Pre s orte d Sta n d ard
banon Jct. K Y
A C S Surgery N e ws C H A N G E SE R VIC E R E Q U ES T E D
151 Fairchild Ave.,
S uite 2,
Plainvie w, N Y 11803-1709
See Congress Â page 7
8 l Letter
Dr. David Graham offers an
alternative to the ABS
11 l News
A study has found that some
benefits of bariatric surgery fade
15 l Practice Economics
Overpayment rulings could trigger
more lawsuits against physicians.
Postop Cognitive Decline
View a video interview with Dr. Katie
J. Schenning on heightened risk
among elderly women.
By Elizabeth Mechcatie
Frontline Medical News
The intragastric balloon is poised to become a weapon in the armamentarium to help
obese patients lose weight.
These devices are designed to be used
in conjunction with other weight loss
strategies and are recommended for obese
patients for whom diet and exercise alone
have not been successful. The balloon is
inserted by way of a minimally invasive endoscopic procedure.
Clinical trials have shown some success
of the intragastric balloon (IGB) but have
also found a significant number of complications, such as digestive hemorrhage
and intraperitoneal abscess, compared with
The prospective BIGPOM (Balloon Intra
Gastrique Préopératoire Pour Obésité Mor-bide) study randomly assigned 60 patients
to standard medical care and 55 to an air- or
water-flled IGB for 6 months before laparoscopic bypass surgery. The average body mass
See Balloons Â page 16
A vast range of opportunities available.